FDA approves ViiV Healthcare’s Triumeq tablets for treatment of HIV-1 infection


Posted in: Disease/Infection News | Pharmaceutical News

Tags: Abacavir, AIDS, Antiretroviral, Breastfeeding, CDC, Cell, Creatinine, DNA, Drugs, Efavirenz, Emtricitabine, Fatigue, Genetic, Headache, Healthcare, Hepatitis B, Hepatitis B Virus, Hepatitis C, Hepatomegaly, HIV, HIV/AIDS, Hypersensitivity, Immunodeficiency, Insomnia, Lamivudine, Nucleoside, Nursing, Pfizer, Pregnancy, Ribavirin, RNA, Steatosis, Tenofovir, Virus, Viruses